OncoCyte
- Country
- Ownership
- -
- Employees
- 46
- Market Cap
- -
- Introduction
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Predictive Assay for Decision Making in Adjuvant Therapy
Terminated
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Drug: AdjuvantOther: Observation
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- OncoCyte
- Target Recruit Count
- 55
- Registration Number
- NCT05032352
- Locations
- 🇺🇸
George Washington Medical Faculty Associates, Washington, District of Columbia, United States
🇺🇸City of Hope National Medical Center, Duarte, California, United States
🇺🇸MedStar Washington Hospital Center, Washington, District of Columbia, United States
© Copyright 2025. All Rights Reserved by MedPath